XML 65 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
QUARTERLY RESULTS (UNAUDITED) (Tables)
12 Months Ended
Jun. 30, 2017
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information [Table Text Block]
Quarters Ended
 
 
Sep 30
 
Dec 31
 
Mar 31
 
Jun 30
 
Total Year
NET SALES
2016-2017
 
$
16,518

 
$
16,856

 
$
15,605

 
$
16,079

 
$
65,058

 
2015-2016
 
16,527

 
16,915

 
15,755

 
16,102

 
65,299

OPERATING INCOME
2016-2017
 
3,771

 
3,875

 
3,360

 
2,949

 
13,955

 
2015-2016
 
3,768

 
3,853

 
3,318

 
2,502

 
13,441

GROSS MARGIN
2016-2017
 
51.0
%
 
50.8
%
 
49.8
%
 
48.4
%
 
50.0
%
 
2015-2016
 
50.7
%
 
50.0
%
 
49.8
%
 
47.9
%
 
49.6
%
NET EARNINGS:
 
 
 
 
 
 
 
 
 
 
 
Net earnings from continuing operations
2016-2017
 
$
2,875

 
$
2,561

 
$
2,556

 
$
2,202

 
$
10,194

 
2015-2016
 
2,777

 
2,905

 
2,337

 
2,008

 
10,027

Net earnings/(loss) from discontinued operations
2016-2017
 
(118
)
 
5,335

 

 

 
5,217

 
2015-2016
 
(142
)
 
323

 
446

 
(50
)
 
577

Net earnings attributable to Procter & Gamble
2016-2017
 
2,714

 
7,875

 
2,522

 
2,215

 
15,326

 
2015-2016
 
2,601

 
3,206

 
2,750

 
1,951

 
10,508

DILUTED NET EARNINGS PER COMMON SHARE: (1)
 
 
 
 
 
 
 
 
 
 
 
Earnings from continuing operations
2016-2017
 
$
1.00

 
$
0.93

 
$
0.93

 
$
0.82

 
$
3.69

 
2015-2016
 
0.96

 
1.01

 
0.81

 
0.71

 
3.49

Earnings/(loss) from discontinued operations
2016-2017
 
(0.04
)
 
1.95

 

 

 
1.90

 
2015-2016
 
(0.05
)
 
0.11

 
0.16

 
(0.02
)
 
0.20

Net earnings
2016-2017
 
0.96

 
2.88

 
0.93

 
0.82

 
5.59

 
2015-2016
 
0.91

 
1.12

 
0.97

 
0.69

 
3.69


(1) 
Diluted net earnings per share is calculated on Net earnings attributable to Procter & Gamble.